No Cover Image

Journal article 541 views 151 downloads

Dapagliflozin is associated with improved glycaemic control and weight reduction at 44 months of follow-up in a secondary care diabetes clinic in the UK

Natasha Shrikrishnapalasuriyar, Ayesha Shaikh, Aliya Mohd Ruslan, Giselle Sharaf, Maneesh Udiawar, David E. Price, Jeffrey Stephens Orcid Logo

Diabetes & Metabolic Syndrome: Clinical Research & Reviews, Volume: 14, Issue: 3, Pages: 237 - 239

Swansea University Author: Jeffrey Stephens Orcid Logo

  • 53936.pdf

    PDF | Accepted Manuscript

    Released under the terms of a Creative Commons Attribution Non-Commercial No Derivatives License (CC-BY-NC-ND).

    Download (123.77KB)
Published in: Diabetes & Metabolic Syndrome: Clinical Research & Reviews
ISSN: 1871-4021
Published: Elsevier BV 2020
Online Access: Check full text

Tags: Add Tag
No Tags, Be the first to tag this record!
Keywords: Dapagliflozin; SGLT2 inhibitor; HbA1c; Cardiovascular
Issue: 3
Start Page: 237
End Page: 239